A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)
Philip Beale(The University of Sydney), L Etterley(Cancer Research UK)
Cited by 44
Related Papers
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
|Clinical Cancer Research|2017|95
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors
|Gynecologic Oncology|2019|88
Patterns of platinum drug use in an acute care setting: a retrospective study
|Journal of Cancer Research and Clinical Oncology|2018|31
Paragon (ANZGOG-0903)
|International Journal of Gynecological Cancer|2017|22
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer
|International Journal of Gynecological Cancer|2021|12